Publication:
Study of the combination gemcitabine and trastuzumab in the treatment of HER2+ metastatic breast cancer

Simple item page
dc.conference.date20-22 June 2007
dc.conference.placeMadrid
dc.conference.titleVII Madrid Breast Cancer Conference: Changes in the treatment of breast cancer.
dc.contributor.authorMenjón-Beltrán, S
dc.contributor.authorOlivencia-Dueso, R
dc.contributor.authorGonzález-Jiménez, E
dc.contributor.authorTitos, MJ
dc.contributor.authoraffiliation[Menjón-Beltrán,S; Olivencia-Dueso,R; González-Jiménez,E; Titos,MJ] Unidad de Ginecología Oncológica, Hospital Universitario Virgen de las Nieves, Granada, Spain.es
dc.date.accessioned2012-10-10T11:37:42Z
dc.date.available2012-10-10T11:37:42Z
dc.date.issued2007-06-19
dc.descriptionPoster Presentation. This article is part of the supplement: VII Madrid Breast Cancer Conference: Changes in the treatment of breast cancer.es
dc.description.abstractTrastuzumab and gemcitabine are two active drugs for meta-static breast cancer (MBC) treatment. We conducted a retrospective study of this combination in patients with Her2+ MBC in our hospital.es
dc.description.versionYeses
dc.identifier.citationMenjón-Beltrán S, Olivencia-Dueso R, González-Jiménez E, Titos MJ .Study of the combination gemcitabine and trastuzumab in the treatment of HER2+ metastatic breast cancer. Breast Cancer Research 2007, 9(Suppl 1):P11es
dc.identifier.doi10.1186/bcr1717
dc.identifier.essn1465-542X
dc.identifier.issn1465-5411
dc.identifier.urihttp://hdl.handle.net/10668/556
dc.journal.titleBreast Cancer Research
dc.language.isoen
dc.publisherBioMed Centrales
dc.relation.publisherversionhttp://breast-cancer-research.com/content/9/S1/P11es
dc.rights.accessRightsopen access
dc.subjectAnticuerpos Monoclonales Humanizadoses
dc.subjectAntineoplásicoses
dc.subjectNeoplasias de la Mamaes
dc.subjectMetástasis de la Neoplasiaes
dc.subjectAntimetabolitos Antineoplásicoses
dc.subjectFemeninoes
dc.subjectHumanoses
dc.subjectReceptor erbB-2es
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal::Antibodies, Monoclonal, Humanizedes
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agentses
dc.subject.meshMedical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Breast Neoplasmses
dc.subject.meshMedical Subject Headings::Diseases::Neoplasms::Neoplastic Processes::Neoplasm Metastasises
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Antimetabolites::Antimetabolites, Antineoplastices
dc.subject.meshMedical Subject Headings::Check Tags::Femalees
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humanses
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Protein Kinases::Protein-Tyrosine Kinases::Receptor Protein-Tyrosine Kinases::Receptor, erbB-2es
dc.titleStudy of the combination gemcitabine and trastuzumab in the treatment of HER2+ metastatic breast canceres
dc.typeconference poster
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Menjon_StudyOfThe.pdf
Size:
45.41 KB
Format:
Adobe Portable Document Format
Description:
Poster presentation
Download

Collections

SAS - Hospital Universitario Virgen de las Nieves

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía